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Mesoporous silica materials have the ability to entrap drugs, nutrients and functional 21 
biomolecules and can be able to act as smart delivery systems capable to control and target 22 
the release of their cargo in a particular part of the gastrointestinal tract when administrated 23 
orally. However, the aptness of these encapsulation supports in in vivo oral controlled release 24 
relies on their chemical stability through the digestive tube. In this context, we have evaluated 25 
the stability of four different mesoporous silica particles, frequently used as encapsulating 26 
supports, during an in vitro digestion process comprising buccal, stomach and intestinal 27 
phases. Results showed that after 4 h of digestion, the textural properties of silica supports in 28 
the form of nanoparticles (MCM-41 and UVM-7 nanoparticles) were lost in varying degrees, 29 
whereas silica microparticles supports (MCM-41 and SBA-15 microparticles) endures better the 30 
digestion process. Moreover, the functionalization of the surface with N1-(3-31 
trimethoxysilylpropyl)diethylenetriamine, an organic moiety commonly used in the 32 
preparation of pH-responsive mesoporous silica particles, resulted in an improvement of the 33 
stability of the supports.  34 
 35 
 36 
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1.  Introduction 38 
Mesoporous Silica Particles (MSPs) are receiving great attention in the field of oral 39 
controlled release due to their capability to improve drug solubility and stability in the 40 
gastrointestinal tract (GIT), [1-2] as well as to dosage the cargo along time (sustained 41 
controlled release) in specific GIT places (targeted controlled release) [3-5]. These reported 42 
features, that convert MSPs in unique smart delivery systems, are due to their large loading 43 
capacity [6], low toxicity [7] and the fact that their surface can be functionalized with 44 
molecular/supramolecular ensembles. This last feature allows the development of gated-MSPs 45 
showing “zero delivery” and capable to release their cargo on-command in response to 46 
specifically designated external stimuli [8-10]. Drug delivery/formulation technologies that can 47 
improve bioavailability, drug stability and subsequently increase drug effectiveness are much 48 
desired in the pharmaceutical sciences [11-12]. In food technology, encapsulation of bioactive 49 
molecules (e.g. vitamins, antioxidants, phytochemicals, etc.) may improve their biological 50 
stability, facilitate components handling, mask unpleasant sensorial properties and modulate 51 
the bioaccessibility of the molecule of interest along the GIT [13]. 52 
Besides a high loading capacity, controlled release and biocompatibility, the suitability of 53 
MSPs in oral controlled release in in vivo applications depend on the chemical stability of the 54 
supports though the whole digestive tube. However, it is known that due to the metastability 55 
of MSPs, silica can be biodegraded into silicic acids, including monomeric silicic acid and 56 
various polysilicic acids with different polymerization degrees under harsh environments 57 
provoking a collapse of the porous structures [14]. In this line, Cauda, Schlossbauer & Bein 58 
studied the biodegradation of colloidal mesoporous silica nanoparticles (50 nm) in simulated 59 
body fluid of bare, globally functionalized, and surface poly(ethylene glycol)-coated colloidal 60 
mesoporous silica nanoparticles in simulated body fluid (pH 7.4) for a period of 1 month at 37 61 
°C [15]. After this period of time, the textural properties of the mesoporous system were lost 62 
and pores were blocked because the precipitation of inorganic components from the 63 
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simulated body solution. The stability of the particles increased by surface functionalization 64 
with poly(ethylene glycol). The degradation behaviour of surfactant-extracted mesoporous 65 
silica in simulated body fluid was also evaluated by He and co-workers proposing a three-stage 66 
degradation process comprising a fast bulk degradation on hour-scale, a silicon concentration 67 
decrease stage due to a deposition of a calcium/magnesium silicate layer, and a later 68 
continuous sustained diffusion beyond days [16]. The same year, Lin, Abadeer & Haynes, 69 
evaluated the stability of small mesoporous silica nanoparticles (<50 nm) functionalised with 70 
poly(ethylene glycol) in H2O, phosphate buffer solution (PBS) (pH 7.5), and Dulbecco’s 71 
modified Eagle’s medium (DMEM) with 10% fetal bovine serum (FBS) (pH ca. 7.5) [17]. These 72 
particles exhibited long term stability in all these media at both, room and physiological 73 
temperature. In a different attempt, El Mourabit et al. studied the stability of mesoporous 74 
silica under acidic conditions and a loss of textural properties of the supports was observed 75 
[18]. The authors also found that the degradation rate was dependent on the nature of the 76 
acidic media (phosphoric acid have stronger impact than hydrochloric or sulphuric acids) and 77 
the kind of mesoporous silica used in the study. More recently, Choi et al. studied the 78 
biodegradation of SBA-15 in both, simulated body fluid and in vivo [19]. These authors have 79 
shown that the degradation rate of SBA-15 was affected by the presence of surface functional 80 
groups and synthesis methodologies. Furthermore, in vivo experiment showed that SBA-15 81 
degrade in the animal and pore structure deformation occurs as a function of time. 82 
Most of these studies evaluated the stability of mesoporous silica nanoparticles. However, 83 
MSPs can be fabricated with a controlled size from 50 nm to a few microns. When preparing 84 
smart delivery systems based on MSPs, particle size is very important since it conditions the 85 
distribution and behavior of particles in living systems. In general, small MSPs can cross 86 
epitheliums, can be distributed in the body and be non-specifically internalized by certain cells 87 
[20]. In contrary, oversized particles (microparticles) cannot easily cross physical membranes in 88 
the body, and thus large particle sizes are preferred for developing orally administrated 89 
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controlled release devices [4]. Having in mind the importance of particle size in oral 90 
administration, it may be of importance to study the stability of mesoporous silica with micro-91 
sized particles. However, stability of large MSPs has been barely studied. Moreover, as far as 92 
we know, there are not studies about the effect that the consecutive presence of saliva (pH 93 
7.5), gastric (pH 1.2-2) and intestinal fluids (pH 7.8-8) have on the stability of the small and 94 
large MSPs. Thus, notwithstanding the works detailed above, a lack of information about the 95 
degradability/stability of MSPs with different sizes during a whole digestion is still unavailable.  96 
The aim of this study was to evaluate the stability of different bare and functionalised 97 
mesoporous silica particles differing in particle size, particle shape and pore structure (pore 98 
size and wall thickness) during a simulated in vitro digestion. With this purpose a deep 99 
evaluation of the stability of textural properties of MSPs during the in vitro digestion was 100 
performed. Descriptive studies were completed with the assessment of potential cytotoxicity 101 
of digested particles or their degradation products. 102 
2. Materials and methods 103 
2.1 Chemicals 104 
Tetraethylorthosilicate (TEOS), N-cetyltrimethylammonium bromide (CTABr), Pluronic 105 
P123 (P123), triethanolamine (TEAH3), sodium hydroxide (NaOH), hydrochloric acid (HCl), N
1-106 
(3-trimethoxysilylpropyl)diethylenetriamine (N3), and all chemicals for the preparation of the 107 
simulated digestive fluids were provided by Sigma-Aldrich (Poole, Dorset, UK). HPLC grade 108 
acetonitrile was provided by Scharlau (Barcelona, Spain). Rhodamine B was acquired from 109 
Fluka (Missouri, USA).  110 
For cell culture experiments, trypan blue solution (0.4%) cell culture grade and dimethyl 111 
sulfoxide (DMSO), phosphate buffered saline (PBS) and Dulbecco's Modified Eagle's medium 112 
(DMEM) with glucose, L-glutamine and pyruvate for cell culture were provided by Sigma-113 
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Aldrich (Poole, Dorset, UK). Mc Coy’s 5a Medium and Keratinocyte Serum Free Medium, Fetal 114 
Bovine Serum (FBS) and trypsin were purchased from Gibco (Life Technologies, Madrid, Spain). 115 
Cell proliferation reagent WST-1 was purchased from Roche Applied Science (Barcelona, 116 
Spain).  117 
2.2 Mesoporous silica particles synthesis 118 
Synthesis of the four different silica particles was carried out following the procedures 119 
described previously [4].   120 
MCM-41 (M) was synthesized following the so-called “atrane route”, using CTABr as the 121 
structure-directing agent and a molar ratio fixed to 122 
7TEAH3:2TEOS:0.52CTABr:0.5NaOH:180H2O. The procedure consisted in adding CTABr to a 123 
solution of TEAH3 and NaOH containing TEOS at 118 °C. After dissolving CTABr in the liquor, 124 
water was slowly added with vigorous stirring at 70 °C to form a white suspension. This 125 
mixture was aged at room temperature overnight. 126 
Nanoparticulated MCM-41 (N) was synthesized using the following procedure: NaOH was 127 
added to the CTABr solution, followed by adjusting the solution temperature to 95 °C. TEOS 128 
was then added dropwise to the surfactant solution. The mixture was allowed to stir for 3 h to 129 
give a white precipitate. 130 
UVM-7 (U) was synthesised using, once again, the “atrane route”. The molar ratio of the 131 
reagents in the mother liquor was fixed at 7TEAH3:2TEOS:0.52CTABr:180H2O. The TEOS/TEAH3 132 
mixture was heated to 120 °C until no elimination of ethanol was observed. The mixture was 133 
cooled to 90 °C and the CTABr was added gradually in small portions, followed by water. The 134 
mixture was aged for 24 h. 135 
The SBA-15 (S) sample was synthesized using P123 as the structure-directing agent with 136 
the reactant molar ratios: 0.017P123:1.0TEOS:6HCl:196H2O. The preparation was carried 137 
mixing an aqueous solution of P123 with HCl solution, and stirring for 2 h, after which the silica 138 
source, TEOS, was added. This final mixture was stirred for a further 20 h. 139 
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After the synthesis, the different solids were recovered, washed with deionised water, 140 
and air-dried at room temperature. The as-synthesized solids were calcined at 550 °C using an 141 
oxidant atmosphere for 5 h in order to remove the template phase. 142 
The particles were also functionalised with N1-(3-trimethoxysilylpropyl)diethylenetriamine 143 
(N3). In particular, 1 g of the different MSPs were suspended in 40 mL of acetonitrile and an 144 
excess of N3 (4.3 mL, 15.0 moll g-1) was then added. Final mixtures were stirred for 5.5 h at 145 
room temperature. Finally, the solids were filtered off, washed with 30 mL of deionised water, 146 
and dried at room temperature.  147 
2.3 Simulated digestion procedure 148 
An in vitro digestion model consisting of mouth, gastric and intestinal phases described by 149 
Versantvoort et al. was used to simulate the typical chemical composition, pH and residence 150 
time periods of each of the three main compartments of the GIT [21]. A schematic 151 
representation of the in vitro digestion model is presented in Figure 1. The pH values of the 152 
digestive juices were checked and, if necessary, adjusted to the appropriate interval with 153 
NaOH (1 M) or HCl (37% w/w). 154 
 155 





Figure 1. Schematic representation of the in vitro digestion process. The in vitro digestion model describes a three-158 
step procedure simulating the digestive processes in mouth, stomach and small intestine. In each compartment, the 159 
matrix is incubated at 37 °C for a time relevant for the compartment. The digestion is initiated by addition of 160 
artificial saliva to the material. Subsequently, gastric juices and intestinal fluids are added to simulate the digestive 161 
processes in stomach and small intestine, respectively. After each of these steps, samples were taken to conduct 162 
characterization procedures. Characterization typically involves microscopy, PXRD, size distribution, zeta potential, 163 
N2 adsorption-desorption isotherms, 
29
Si RMN, silicon analysis and biocompatibility using WST-1 test.   164 
 165 
2.4 Characterization of the mesoporous silica particles 166 
All materials, as synthetized and after a simulated digestion process, were characterized 167 
by standard procedures: i.e. X-ray diffraction (XRD), N2 adsorption-desorption isotherms, 168 
transmission electron microscopy (TEM), field emission scanning electron microscopy (FESEM), 169 
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confocal laser scanning microscopy (CLSM), 29Si nuclear magnetic resonance (NMR), particle 170 
size distribution and zeta potential measurements. 171 
XRD were performed on a Bruker D8 Advance diffractometer (Bruker, Coventry, UK) using 172 
CuKα radiation. N2 adsorption-desorption isotherms were recorded with a Micromeritics ASAP 173 
2010 automated sorption analyser (Micromeritics Instrument Corporation, Norcross, USA). The 174 
samples were degassed at 120 °C in vacuum overnight. The specific surface areas were 175 
calculated from the adsorption data in the low pressure range using the BET model. Pore size 176 
was determined following the BJH method.  177 
The effect of digestion on single particle surface and morphology was evaluated through 178 
electron microscopy observations. TEM images were obtained with a JEOL JEM-1010 (JEOL 179 
Europe SAS, Croissy-sur-Seine, France). FESEM images were acquired with a Zeiss Ultra 55 (Carl 180 
Zeiss NTS GmbH, Oberkochen, Germany) and observed in the secondary electron mode. 181 
To determine the changes of MSPs structures and aggregation state along the whole in 182 
vitro digestion procedure, confocal laser scanning microscopy (CLSM) micrographs were taken. 183 
Three aliquots were taken from the digestion solution at 5 min, 2 and 4 h, just after finishing 184 
the mouth, stomach and intestine steps respectively. Samples were stained with 20 µL of 185 
rhodamine B solution (2 g L-1). The observations were made 10 min after the dyes were added. 186 
Pictures were acquired using a Nikon Eclipse E800 microscope (Nikon, Tokyo, Japan). An Ar 187 
laser line (488 nm) was used to excite the rhodamine B. The images were obtained and stored 188 
at a 1,024 × 1,024-pixel resolution using the microscope software (EZ-C1 v.3.40, Nikon, Tokyo, 189 
Japan). 190 
Microscopic studies were completed by determining the particle size distribution and 191 
surface charge at the interface of different MSPs during the in vitro digestion process. To avoid 192 
interference of organic components (sugars, enzymes, etc.) in measured values, digestive 193 
fluids addressed to determination of size distribution and zeta potential were prepared with 194 
only the inorganic components [22]. Size distribution of MSPs after each of the digestion steps 195 
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(mouth, stomach and intestine) was measured by means of Laser Diffraction (LD) and Dynamic 196 
Light Scattering (DLS). LS determinations were performed with a Malvern Mastersizer 2000 197 
(Malvern Instruments, Malvern, UK). For data evaluation, an optical model based on the Mie 198 
theory was created using the instrumental software assuming 1.45 as the real and 0 as the 199 
imaginary part of the refractive index of the particles. DLS determinations were performed in a 200 
Zetasizer Nano ZS equipment (Malvern Instruments, Malvern, UK). The surface charge at the 201 
interface of the MSPs or zeta potential (), after each of the in vitro digestion steps, was 202 
measured at 25 °C in a Zetasizer Nano ZS equipment (Malvern Instruments, Malvern, UK). The 203 
zeta potential was calculated from the particle mobility values by applying the Smoluchowski 204 
model. The average of five recordings was reported as zeta potential. The measurements were 205 
performed at 25 °C. Zeta potential distributions were obtained by averaging 3 measurements.   206 
29Si MAS NMR spectra were recorded on a Varian Unity 300 spectrometer operating at 207 
79.5 MHz, with a magic angle spinning speed of at least 4.0 kHz. Comparison of the 29Si NMR 208 
spectra before and after digestion allowed evaluating the local degradation of the silica surface 209 
through rupture of S-O-Si siloxane bonds and the subsequent increment in the proportion of 210 
Si-OH terminal silanol groups.  211 
2.5 Quantification of silicon content in digestion fluids 212 
For the determination of the free silicon generated during the digestion process, digestion 213 
juices were centrifuged (9500 rpm; 10 min) to separate digested MSPs from the aqueous 214 
solution. The degraded silicon concentration in the supernatant was determined by inductively 215 
coupled plasma optical emission spectrometry (ICP-OES) using a Horiba Jobin Yvon ULTIMA 2 216 
spectrometer (Longjumeau, France). Before the analysis, the recovered supernatants were 217 
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2.6 WST-1 Cell viability Assays 222 
HeLa human cervix adenocarcinoma and HEPG2 human liver carcinoma were grown in 223 
DMEM supplemented with 10% FBS. HCT116 human colon carcinoma cells were grown in 224 
McCoy's 5a Medium Modified supplemented with 10% FBS and HK2 homo sapiens kidney 225 
papilloma cells were grown in Keratinocyte Serum Free Medium supplemented with bovine 226 
pituitary extract (BPE) and human recombinant epidermal growth factor (EGF). All cells were 227 
purchased from the German Resource Centre for Biological Materials (DSMZ). Cells were 228 
maintained at 37 °C in an atmosphere of 5% carbon dioxide and 95% air and underwent 229 
passage twice a week.  230 
Cells were placed in 96-well plates at a density of 1000 cells per well. After 24 h, plates 231 
were incubated with the digestion fluids containing MSPs at different concentrations at 37 °C 232 
for 24 h. After removing the digestive medium containing the MSPs, MTT solution (200 mL, 1 233 
mg mL-1) was added and the cells were incubated for another 3 h. Upon removal of the MTT 234 
solution, the purple formazan crystals were solubilized with DMSO (200 mL) and measured at 235 
560 nm on a microplate reader (SPECTRAmax plus, Molecular Devices, Sunnyvale, CA). The 236 
cytotoxicity was expressed as percentage of cell viability. 237 
3. Results and discussion 238 
3.1 Preparation and characterization of the mesoporous silica supports  239 
Four mesoporous silica particles differing in size, shape, and pore structure were 240 
prepared following the procedures described by previous reports (vide ante). M are porous 241 
irregular-shaped particles of ca. 1 m with a 2D-hexagonal pore arrangement and pore size in 242 
the 2-3 nm range. With the same porous structure, N are spherical particles of ca. 100 nm. U 243 
support are porous nanoparticles organized in the form of clusters creating a bimodal system 244 
of pores (mesopores and structural micropores). Finally, S are elongated particles of ca. 1 m 245 
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with a well-defined hexagonal distribution of mesopores ranging from 5-8 nm. These particles 246 
were used as models to evaluate the effect of human digestion on the stability of MSPs as well 247 
as to assess the cytotoxicity of digested MSPs in four different cell lines. 248 
After the synthesis, the prepared MSPs were characterised using standard procedures. 249 
The mesostructure of different supports was characterised by X-Ray diffraction. As expected, 250 
the four mesoporous supports exhibited typical diffraction patterns. Figure 2a and 2b show 251 
the diffractograms of M and N solids, respectively. Curves (i) for both particles display the 252 
hexagonal ordered array of the MCM-41 family characterized by the presence of three typical 253 
peaks, indexed as (100), (110) and (200) Bragg reflections [4]. Similarities in peaks positions 254 
and full width at half maximum between the two curves confirm that the change in the particle 255 
size (nano or micro) does not have any influence in the porous structure of the particles.  256 
Likewise, Figures 2c and 2d show typical diffractograms of S and U solids, respectively [4]. 257 
Curve (i) of figure 2c shows the typical pattern of S solid, characterised by a sharp peak at 258 
21.0, indexed as the (100) reflection, and two minor peaks in the 1.0-2.0 interval, indexed 259 
as (110) and (200) Bragg reflections, respectively. On the other hand, curve (i) of figure 2d 260 
presents two broad low-angle reflections that is most likely related with a disordered 261 
hexagonal array of the mesopores in the U support. Moreover, in all cases the 262 
functionalization of the particles with N3 (curves iii) does not modify the typical porosity of the 263 
mesoporous scaffolds, since the (100) peak is present in all cases. 264 
 265 




Figure 2. Powder X-ray patterns of as-synthesised MSPs before (i) and after the in vitro digestion (ii) as well as 267 
amine-functionalised MSPs before (iii) and after (iv) the in vitro digestion. MCM-41 microparticles (M) (a), MCM-41 268 
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Characterization of textural properties was complemented by performing N2 adsorption-273 
desorption isotherms. Table 1 list BET specific surface values, pore volumes, and pore sizes of 274 
the particles object of study. As observed, before the digestion process, all the synthesized 275 
bare particles exhibited large pore volumes and large surface areas due to the presence of the 276 
mesopores. 277 
 278 
Table 1. BET specific surface values, pore volumes and pore sizes calculated from the N2 279 
adsorption-desorption isotherms for selected materials. MCM-41 micro (M), MCM-41 nano 280 
(N), SBA-15 (S) and UVM-7 (U). 281 
 282 




















M 1.1±0.2 1063 0.95 2.65 2.05 
N 0.09±0.02 1070 0.92 2.53 1.91 
S 1.2±0.2 642 0.93 7.82 2.56 
U 1.2±0.3 981 0.72 2.62 2.22 
a. Pore volumes and pore sizes are only associated with intraparticle mesopores. 283 
b.  Pore size estimated by using the BJH model applied on the adsorption branch of the isotherm. 284 
c. Wall thickness was estimated as cell parameter taken from the XRD minus pore size.  285 
 286 
3.2 Effect of in vitro digestion in microstructure of bare particles 287 
To test the effect of human digestion on bare MSPs stability a typical in vitro digestion 288 
procedure was followed (Figure 1). After the digestion process, particles were washed with 289 
water, recovered by centrifugation and characterized.  290 
The XRD diffractograms (Fig 2) revealed an important loss of the order in all bare digested 291 
particles (ii) characterized by a decreased intensity of the (100) Bragg peak and a loss of almost 292 
the rest of reflections when compared with undigested ones (i). The loss of intensity followed 293 
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the order N (wall thickness = 1.91), closely followed by M (wall thickness = 2.05) and U (wall 294 
thickness = 2.22). The differences in wall thickness among N (less than 2 nm) and M and U 295 
(more than 2 nm) might be due to the synthesis route. N and U follow the atrane route of 296 
synthesis, a procedure that provides wide framework walls.  297 
For its part, S with a wall thickness of 2.56 nm seemed to be the particle that better conserve 298 
the hexagonal structure of the particle. In fact the diffractogram of digested S was very similar 299 
than that of the undigested particle meaning that mesoporous arrangement is preserved 300 
during the in vitro digestion procedure. In short, the pore wall thickness seems to be the key 301 
factor to preserve the mesostructure integrity, being the silica stability highly favoured when 302 
the pore wall thickness increases. 303 
Nitrogen sorption data (Fig 3) show a reduction of the adsorbed N2 volume in all solids, 304 
which suggested that the digestion procedure provokes a loss of specific surface area and pore 305 
volume. This reduction is more marked in the case of N (177 m2 g-1; 0.29 cm3 g-1) and U (372 m2 306 
g-1; 0.78 cm3 g-1) that in M (321 m2 g-1; 0.46 cm3 g-1) and S (368 m2 g-1; 0.62 cm3 g-1) in consonance 307 
with XRD patterns. This loss of surface area and pore volume as a consequence of the contact 308 
with biological media has also been observed by other authors [15,18].  In these works, the 309 
loss of textural properties of silica supports was associated with a progressive elimination of 310 
the porosity by dissolution of the silica or by pore blockage due to precipitation of inorganic 311 
compounds onto the surface of the porous silica. The combined result of silica redisolution and 312 
salt precipitation has a marked effect on the form of the isotherms. In fact, only SBA-15 shows 313 
after digestion a N2 adsorption-desorption isotherms qualitatively similar to the original one, 314 
with a well-defined adsorption step at relative pressure values in the 0.6-0.8 range. In the case 315 
of the remaining silica supports with thicker walls (M and U), the loss of surface area and 316 
volume seems to be more pronounced than the mesostructural disorder evidenced through 317 
XRD. At this point, probably the existence of small mesopores for samples M, N and U (ca. 2.5 318 
nm) leads to an easier pore blocking through salt reprecipitation with the subsequent 319 
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significant loss of surface and pore volume. In contrast, the larger values of the voids and the 320 
walls in the S support favours the preservation of the mesostructure and hinder pore blocking. 321 
 322 
 323 
Figure 3. Nitrogen adsorption-desorption isotherms for microparticulated MCM-41 (M) (a), nanoparticulated MCM-324 
41 (N) (b), SBA-15 (S) (c) and UVM-7 (U) (d) before (i) and after (ii) the in vitro digestion procedure. 325 
 326 
To further understand which of these mechanisms are involved in the digestion-induced 327 
silica degradation, in parallel to XRD and N2 absorption-desorption isotherms experiments, 328 
TEM and FESEM observations of the four silica supports were carried out. Figure 4 shows 329 
FESEM and TEM pictures of different bare particles before and after the in vitro digestion 330 
process. This figure allows observing not only the particle size and shape of the single particle, 331 
but also particle porosity.  332 
After the digestion, two particles did not modify their appearance (FESEM) and pore 333 
integrity (TEM). These particles are M and S which are particle with size in the microscale. This 334 
implies that for these particles the loss of order observed in XRD was not provoked by a 335 
collapse of the mesostructure, but probably by the formation of a small volume fraction of 336 
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“gel” consisting mostly of (SiOH2)n
18 or the adsorption of calcium and phosphate ions present 337 
in the digestion fluids on the silica surface forming a hydroxyapatite phase [15, 23-25].  338 
In contrast, supports based on nanoparticulated materials, N and U biodegraded with a 339 
modification of the appearance of both, surface and pore structure as a consequence of the 340 
digestion procedure. Concretely, the most affected support was N. After the whole digestion 341 
process, N and U nanoparticles lost the uniformity of pore structure (see TEM images) and 342 
despite keeping its particle size and shape, there is a clear alteration of the surface (FESEM). In 343 
those cases, besides the pore closure provoked by the apparition of new phases, the decrease 344 
of the mesostructure observed by XRD and N2 adsorption-desorption isotherms can also be 345 
originated, at least partially, by pore collapse. 346 
 347 




Figure 4. Characterization of particle size, particle shape and pore system of bare MSPs before and after the in vitro 349 
digestion procedure (IDP). MCM-41 (M), MCM-41 nano (N) SBA-15 (S) and UVM-7 (U). 350 
 351 
Silica degradation necessarily implies the break of siloxane bonds with the subsequent 352 
generation of silanol groups and this was corroborated through the evolution of the 29Si NMR 353 
spectra before and after digestion. For this study we selected two samples (S and N) that can 354 
be considered as representative of the two observed behaviours with low (solid S) and high 355 
(solid N) biodegradation according to TEM images. The 29Si NMR spectra are shown in Figure 5. 356 
While in the case of sample S, the digestion does not affect the proportion of Q4:Q3:Q2 357 
(68:30:2) sites, a decrease of the Q4 sites from 65% to 60% is observed in the case of the N 358 
sample (Q4:Q3:Q2 from 65:31:4 to 60:33:7). 359 







Si NMR spectra for SBA-15 (a) and nanoparticulate MCM-41 (b), before (i) and after (ii) the in vitro 362 
digestion procedure. 363 
 364 
Having in mind these results, it is apparent that all studied MSPs are altered as a 365 
consequence of the in vitro digestion process. However, the degradation degree depends on 366 
the type and size of the particles. In this line, El Mourabit et al. studied the structure alteration 367 
of several porous silica supports differing in particle size, particle shape, pore-size distribution, 368 
specific surface area, pore volume and average of pore diameter caused by immersion in acid 369 
solutions and found that the degradation of the supports was not obviously influenced by 370 
textural properties of the particles [18]. Nevertheless, in our study, it seems to be clear that 371 
particle size and wall thickness seem to be essential parameters that condition degradation. 372 
In order to correlate the impact of each of the phases of the digestion with the particle’s 373 
degradation, a further experiment was done. For this MCM-41 nanoparticles (solid N) were 374 
selected given that this was the most affected support by the whole digestion process. For this 375 
purpose, N was put in contact with water for 4 h. In parallel, a typical in vitro digestion process 376 
(4 h) was performed. After each of these steps, samples were washed and observed by TEM. 377 
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Figure 6 shows TEM micrographs of N after 4 h in contact with water (a) and after each of the 378 
phases of the in vitro digestion process: buccal (b), gastric (c) and intestinal (d). As observed, 379 
the particle size (ca. 100 nm) did not vary along the digestion suggesting that particle structure 380 
remains unaltered after the whole digestion process. Moreover, surface and porosity of MCM-381 
41 remained unchanged after 4 h in water, meaning that particles do not collapse easily in 382 
water solution. Particles are also intact after the 5 min of contact with simulated saliva. 383 
However, particles change dramatically after the 2 h of gastric phase. In particular, after this 384 
digestion step, particles loss clearly their spherical shape and ordered porous conformation 385 
and become irregular shaped spheres with disordered porosity. Little differences among 386 
particles observed after gastric and after both, gastric and intestinal phases were observed 387 
suggesting that once the digestive solution is neutralized by the addition of intestinal juices, 388 
the degradation process stopped. 389 
 390 
 391 
Figure 6. TEM images showing particle size, particle shape and pore system of bare MCM-41 nanopaticles 392 
(solid N) after 4 h in water, and buccal, gastric and intestinal phases of the in vitro digestion procedure.   393 
 394 
These findings confirm that gastric phase (pH 2) is the responsive of particle’s degradation. The 395 
role of acids in porous silica degradation has previously been described [18]. These authors 396 
realised that protons play a role in the acidic alteration process of silica. Moreover, they 397 
pointed out that in acidic conditions, anions (i.e. SO4
2-, Cl-, PO4
3-) present in the media can act 398 
as nucleophilic catalysts accelerating the degradation reactions. Having in mind the 399 
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composition of the two fluids comprising gastric phase of the digestion (i.e. saliva and gastric 400 
juice) it can be say that all these degradative species (i.e. NaSO4, NaH2PO4, HCl, NaCl, KCl, CaCl2 401 
and NH4Cl) are present in our studies.  402 
 403 
3.3 Effect of in vitro digestion in microstructure of amine-functionalised particles 404 
To investigate if the functionalization of the surface of the particles with certain organic 405 
molecules have any influence in the preservation of the structure during the in vitro digestion, 406 
the four particles object of study were functionalised with N1-(3-407 
trimethoxysilylpropyl)diethylenetriamine. This polyamine is one common organic molecule 408 
used to prepare capped mesoporous silica particles able to modulate payload release in 409 
response to pH changes [26]. After functionalization, particles were subjected to the digestion 410 
process described in Figure 1. Digested particles were washed with water, dried and 411 
characterized by XRD, TEM and FESEM. 412 
Figure 2 shows XRD patterns of amine-functionalized particles before (ii) and after (iv) the 413 
in vitro digestion process. In contrast to bare particles, functionalised particles showed the 414 
same diffraction peaks before and after the digestion, which indicate a preservation of the 415 
porous structure after the digestion procedure. The structure preservation was confirmed by 416 
microscopic analysis. As observed in Figure 7, morphology, particle size and porous structure 417 
of the different amine-functionalized supports is very similar before and after the in vitro 418 
digestion process. These studies point out the role played by amines in the protection of 419 
porous silica, especially in the nanoparticles (solids N and U), against the attack by acids and 420 
chemical species present in the digestive juices. The prevention of silica degradation after 421 
organic functionalization has also been observed by other authors. Lin et al. found that 422 
degraded Si amounts from 42 nm diameter silica nanoparticles were greater than that from 423 
the equivalent pegylated nanoparticles after both 10 days in deionized water and PBS at room 424 
temperature and 37 °C [17]. Cauda et al. also observed that the attachment of a poly(ethylene 425 
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glycol)-layer on the outer surface of colloidal mesoporous silica stabilized the particles by 426 
reducing the rate of degradation in simulated body fluid at 37 °C for 1 month [15]. The 427 
preventive effect of functional groups attached to the surface of the silica supports on the 428 
degradation of porous silica could be attributed to the capability of these molecules to inhibit 429 
the attack caused by acids and catalytic anions as well as to prevent the adsorption of 430 
calcium/phosphate cations and the rearrangement of silicon species on a new “gel” fraction on 431 
the walls of the particles.   432 
 433 
 434 
Figure 7. Characterization of particle size, particle shape and pore system of amine-functionalised MSPs before and 435 
after the in vitro digestion procedure. MCM-41 (M), MCM-41 nano (N) SBA-15 (S) and UVM-7 (U). 436 
 437 
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In our study, according to CNH elemental analysis data, the post-functionalization degree 438 
of our samples was comprised in the 0.14-0.15 mol of N1-(3-trimethoxysilylpropyl) groups per 439 
100 g of sample. This value suppose a density of functional groups of ca. 1-1.5 groups/nm2 440 
assuming that their incorporation is effective along the whole surface (external and internal). 441 
As it is well known, the length of this organic group constitutes a serious drawback to achieve a 442 
good diffusion and dispersion along the mesopores. Then, a certain accumulation and 443 
condensation of the organic groups on the external surface and in the entrance of the 444 
mesopores is expected. This relatively thick shell seems to be the responsible for the stability 445 
of the silica supports after digestion. Moreover, in our case, amine groups attached to 446 
particle’s surface can also able to locally neutralize the acidic environment created by HCl. 447 
 448 
3.4 Effect of in vitro digestion in macroscopic structure 449 
To determine the changes of MSPs structures and aggregation state along the whole in vitro 450 
digestion procedure, confocal laser scanning microscopy (CLSM) micrographs were taken upon 451 
staining M, N, S and U supports at different stage of the digestion with rhodamine B (Fig 8). 452 
This study revealed that all the particles tended to form aggregates in water. This trend to 453 
form large aggregates, especially observed in N and U, is in accordance with results previously 454 
reported [27,28]. Figure 8 also allows observing that for all particles the gastric phase trend to 455 
provoke an enlargement of particles aggregates, and that in none of the cases digestion 456 
triggered the loss of macroscopic particle structure.  457 
 458 




Figure 8. Characterization of particle size and particle shape of bare MSPs before and after the in vitro digestion 460 
procedure. MCM-41 micro (M), MCM-41 nano (N), SBA-15 (S) and UVM-7 (U). 461 
 462 
Aggregation tendency observed in gastric phase for all particles was confirmed by particle 463 
size distribution measurements using light diffraction. As shown in Figure 9, according to 464 
particles’ grain size in different digestive media, S and M microparticles, exhibited a size 465 
distribution in the range 0.5-2 m, while size distribution of N and U ranged from 5 up to 40 466 
m. The inset graphs of the same figure shows size distribution of nano-sized silica present in 467 
the digestion fluids. As presumable, only two samples (N and U) also shown particles in the 468 
100-200 nm range, corresponding to those particles not participating in the particle’s clusters.   469 
 470 




Figure 9. Hydrodynamic size distribution of MCM-41 microparticles (M) (a), MCM-41 nanoparticles (N) (b), SBA-15 472 
(S) (c) and UVM-7 (U) (d) expressed as number percentage. Discontinuous gray line (buccal), continuous black line 473 
(gastric) and discontinuous black line (intestinal).  474 
 475 
The tendency to form large silica agglomerates at low pH is also supported by z-potential 476 
values and the extended DLVO theory [22]. Generally, it is considered that particles exhibiting 477 
a zeta potential in the range from +30 to −30 mV tend to aggregate [29]. As observed in Figure 478 
S1, particles exhibited a negative zeta potential (ca. -30 mV) in the presence of saliva (neutral 479 
pH) that changed dramatically during gastric phase (ca. +10 mV) due to the protonation of 480 
silanolates at the pH of the stomach (pH 2) [30]. Moreover, after neutralization in the 481 
intestinal phase, zeta potential reached again negative values of ca -20 - -30 mV, thus reducing 482 
aggregation tendency.   483 
 484 
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3.5 Quantification of silica degradation and degree of silica network condensation  485 
In previous sections, it has been concluded that bare particles, especially N and U, lose 486 
part of their textural properties as a consequence of the in vitro digestion process. It was also 487 
observed, by TEM and FESEM pictures, that stomach phase was the responsive of the 488 
structural changes of the porous systems and changes in the surface appearance. To better 489 
understand the degradation process it was our aim to quantify the amount dissolved silica 490 
obtained during digestion via the quantification of free silicon by ICP-OES as an indicator of 491 
silica degradation [17]. As observed in Table S1, amounts of silicon species in solution in the 492 
digestive juice after the 4 h of digestion process was very similar for all particles (20-25 mg Si L-493 
1 of digestive fluid) and surface functionalization with polyamines did not modify this value. 494 
These amounts of free silicon are equivalent to 4-5% of the silicon present in the starting 495 
MSPs, depending on the support. Thus, as previously indicated, these data suggested that 496 
degradation of porous structure of bare porous silica is not due to a simple dissolution of silica 497 
provoking a collapse of the particle, but by a transformation of the silica in a new disordered 498 
phase. In addition, determination of free silicon formed in the three phases of the digestion of 499 
bare MCM-41 nanoparticles (solid N) revealed that only 0.4% of the silicon was dissolved 500 
during the buccal phase of digestion whereas percentages of dissolved silicon reached values 501 
of 2% in the stomach phase and continued increasing until 4% at the end of the intestinal 502 
phase.   503 
3.6 Biocompatibility of particles after the in vitro digestion 504 
In previous works, we studied the cytotoxicity of the four particles object of study which 505 
were loaded with folic acid and functionalized with N-(3-506 
trimethoxysilylpropyl)diethylenetriamine [4].  The study concluded that functionalised M, N, S 507 
and U particles did not induce significant cell death upon 200 mg mL-1 for 24 h. However, it has 508 
been recently reported  that biodegradation of silica into silicic acids including monomeric 509 
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silicic acid and various polysilicic acids with different polymerization degrees could cause 510 
cytotoxicity via adsorbing and binding enzymes and substrate proteins [16]. 511 
In previous sections it has been demonstrated that MSPs were degraded during the 512 
digestion procedure, and that ca. 4-5% of the silicon present in the MSPs was finally found in 513 
the solution. Thus, with the purpose of evaluate potential side effects of degradation products 514 
of the digested supports on human cells we aimed in this section to study the cytotoxicity of 515 
digestive fluids containing different concentrations of MSPs. To test cytotoxicity, human colon 516 
carcinoma cells (HCT116), human liver carcinoma cells (HEPG2), human kidney epithelial cells 517 
(HK2), and human cervix carcinoma cells (HeLa) cells were chosen. Studies were carried out 518 
with both, bare and amine-functionalised M, N, S and U particles after the in vitro digestion 519 
procedure described above.   520 
The results in Figure S2 and Figure S3 show that the viability of none of the cell line was 521 
compromised even when exposed at different digestive fluids containing relatively large 522 
concentrations MSPs (up to 200 mg mL-1). As stated above it is considered that polysilicic acids 523 
developed during silica degradation could cause cytotoxicity via adsorbing and binding 524 
enzymes and substrate proteins. In contrast, monomeric silicic acid does not bind proteins and 525 
therefore has no cytotoxicity [16]. Having this in mind, results of this study suggested that 526 
both, the formation of silicic species is relatively low and that the biodegradation products do 527 
not contain large amounts of cytotoxic polysilicic acids with high polymerization degree. 528 
4. Conclusions 529 
The present work has studied the effect of an in vitro digestion process on the stability of 530 
bare and amine-functionalized mesoporous silica particles.  Results showed that bare SBA-15 531 
and MCM-41 microparticles were very stable against degradation. However, supports based 532 
on nanoparticles (i.e. MCM-41 nanoparticulated and UVM-7) exhibited an evident degradation 533 
of its structure characterized by a loss of pore order and surface attack. In the degradation 534 
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process, only ca. 5% of the silicon present in the sample was dissolved in the digestion fluids, 535 
confirming that the degradation process is mainly based in the chemical transformation of the 536 
SiO2 in other phases and not in the loss of matter. This degradation was prevented by the 537 
functionalization of the external surface of the particles with N1-(3-538 
trimethoxysilylpropyl)diethylenetriamine. These findings evidence the importance of particle 539 
size and surface modification on the degradation behaviour during an in vitro digestion 540 
process. In addition, despite the partial dissolution of the particles during the different phases 541 
of the digestion, neither the digested particles nor the biodegradation products show any 542 
toxicity to HCT116, HEPG2 HK2 and HeLa cells. In accordance to these results, the utilization of 543 
mesoporous silica microparticles, and over all, amine-functionalized mesoporous silica 544 
microparticles in the design of oral delivery systems guarantees the chemical stability of the 545 
supports through the whole digestive tube and no signs of toxicity have been observed. 546 
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